Platelets in immune response to virus and immunopathology of viral infections

ED Hottz, FA Bozza, PT Bozza - Frontiers in medicine, 2018 - frontiersin.org
Platelets are essential effector cells in hemostasis. Aside from their role in coagulation,
platelets are now recognized as major inflammatory cells with key roles in the innate and …

Interactions of HIV and antiretroviral therapy with neutrophils and platelets

M Madzime, TM Rossouw, AJ Theron… - Frontiers in …, 2021 - frontiersin.org
Neutrophils are important components of the innate immune system that mediate pathogen
defense by multiple processes including phagocytosis, release of proteolytic enzymes …

[HTML][HTML] National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2

TA Jacobson, KC Maki, CE Orringer, PH Jones… - Journal of clinical …, 2015 - Elsevier
Abstract An Expert Panel convened by the National Lipid Association previously developed
a consensus set of recommendations for the patient-centered management of dyslipidemia …

Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration

CA Sabin, P Reiss, L Ryom, AN Phillips, R Weber… - BMC medicine, 2016 - Springer
Abstract Background In March 2008, the D: A: D study published results demonstrating an
increased risk of myocardial infarction (MI) for patients on abacavir (ABC). We describe …

Use of abacavir and risk of cardiovascular disease among HIV-infected individuals

JL Marcus, RS Neugebauer, WA Leyden… - JAIDS Journal of …, 2016 - journals.lww.com
Background: Evidence is conflicting about the association of abacavir use and
cardiovascular disease (CVD) among HIV-infected individuals. Previous studies may have …

Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV

N Jaschinski, L Greenberg, B Neesgaard, JM Miró… - Aids, 2023 - journals.lww.com
Objective: Assessing whether the previously reported association between abacavir (ABC)
and cardiovascular disease (CVD) remained amongst contemporarily treated people with …

Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV

A Lacey, S Savinelli, EA Barco, A Macken, AG Cotter… - Aids, 2020 - journals.lww.com
Background: Whilst reporting improved renal and bone safety profiles, studies have noted
changes in lipid profiles among people living with HIV (PLWH) receiving antiretroviral …

Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients

NT Funderburg - Current opinion in HIV and AIDS, 2014 - journals.lww.com
HIV-infected patients are at greater risk for both venous and arterial thrombosis. Chronic
immune activation and inflammation in these patients appears to contribute to coagulation …

Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND …

B Neesgaard, L Greenberg, JM Miró… - The lancet HIV, 2022 - thelancet.com
Background Although associations between older antiretroviral drug classes and
cardiovascular disease in people living with HIV are well described, there is a paucity of …

Persistent platelet activation and apoptosis in virologically suppressed HIV-infected individuals

EC Mesquita, ED Hottz, RT Amancio, AB Carneiro… - Scientific reports, 2018 - nature.com
Cardiovascular diseases and thrombotic events became major clinical problems in the
combined antiretroviral therapy (cART) era. Although the precise mechanisms behind these …